Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ <i>ERBB2</i> -Negative Early Breast Cancer

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2025-09-25
DOI
https://doi.org/10.1001/jamaoncol.2025.3700
Citations
12
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
18.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ ERBB2 -Negative Early Breast Cancer

Michael Untch, Juan Pablo Zarate, Sherene Loi, Dennis J. Slamon et al.
12 citations
JAMA Oncology
Advanced Breast Cancer Therapies
18.22
article

Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ ERBB2 -Negative Early Breast Cancer

Michael Untch, Juan Pablo Zarate, Sherene Loi, Dennis J. Slamon, Gabriel N. Hortobágyi, Chiun‐Sheng Huang, Zheng Li, Sorcha Waters, Aditya Bardia, John Paul Crown, Rodrigo Fresco, DA Yardley, Sara A. Hurvitz, Seock‐Ah Im, Daniil Stroyakovskiy, Stephen Chia, Carlos H. Barrios, Peter A. Fasching, Miguel Martín, Rebecca Moroose, F. Visco
article en
12 citations

Abstract

No abstract available for this paper.
JAMA OncologyVol. 11(11)
BC Cancer Agency (CA), National Coalition for Cancer Survivorship (US), The University of Texas MD Anderson Cancer Center (US), Orlando Health (US), University of California, Los Angeles (US), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), University of Washington (US), Peter MacCallum Cancer Centre (AU), Peking Union Medical College Hospital (CN), Seoul National University Hospital (KR), Fred Hutch Cancer Center (US), Sarah Cannon (US), St. Vincent's University Hospital (IE), Novartis (United States) (US), National Taiwan University Hospital (TW), Comprehensive Cancer Center Erlangen (DE), Novartis (Ireland) (IE), Helios Hospital Berlin-Buch (DE), Centro de Investigación Biomédica en Red de Cáncer (ES), Moscow City Oncology Hospital №62 (RU)
Cancer Research Institute, University of Washington, Novartis Pharmaceuticals Corporation, Seoul National University, Universidad Complutense de Madrid, Peter MacCallum Cancer Centre, Seoul National University Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Instituto de Investigación Sanitaria Gregorio Marañón, University of California, Los Angeles, University of Texas MD Anderson Cancer Center, College of Medicine, Seoul National University, BC Cancer Agency
Openalex Percentile: Top 1%
Advanced Breast Cancer Therapies
18.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.